Volume 19, Number 1—January 2013
Research
Vaccination and Tick-borne Encephalitis, Central Europe
Table
Scenario, by age group, y |
Unvaccinated persons
|
Regularly vaccinated persons
|
Irregularly vaccinated persons
|
||||
---|---|---|---|---|---|---|---|
Incidence† | Incidence† | FE, % (95% CI) | Incidence† | FE, % (95% CI) | |||
Best-case‡ | |||||||
0–14 |
1.62 | 0.10 | 94.0 (88.0–97.0) | 0.18 | 88.6 (63.3–96.5) | ||
15–50 |
5.41 | 0.02 | 99.7 (99.3–99.9) | 0.26 | 95.3 (92.9–96.9) | ||
51–60 |
7.60 | 0.13 | 98.2 (96.7–99.1) | 0.31 | 96.0 (91.4–98.1) | ||
>61 |
7.52 | 0.14 | 98.2 (97.0–98.9) | 0.63 | 91.7 (87.9–94.3) | ||
Total |
5.01
|
|
0.07
|
98.7 (98.2–99.0)
|
|
0.37
|
92.5 (90.3–94.3)
|
Worst-case§ | |||||||
0–14 |
1.62 | 0.13 | 92.2 (87.4–97.0) | 0.19 | 88.0 (62.3–96.2) | ||
15–50 |
5.41 | 0.11 | 98.1 (97.4–98.8) | 0.30 | 94.5 (91.9–96.2) | ||
51–60 |
7.60 | 0.25 | 96.8 (95.3–98.4) | 0.39 | 94.9 (89.9–97.4) | ||
>61 |
7.52 | 0.44 | 94.4 (92.8–96.1) | 0.71 | 90.5 (86.4–93.3) | ||
Total |
5.01 | 0.20 | 96.3 (95.5–97.0) | 0.44 | 91.3 (88.9–93.2) |
*TBE, tick-borne encephalitis; FE, field effectiveness.
†Cases/100,000 population.
‡Persons with TBE but unknown vaccination status were excluded.
§Persons with TBE but unknown vaccination status were considered regularly vaccinated.
Page created: December 20, 2012
Page updated: December 20, 2012
Page reviewed: December 20, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.